Quiz: Incidence and Screening in Prostate Cancer

Article

How much do you know about the incidence and screening of prostate cancer? Here's your chance to find out.

In this quiz, you’ll get a chance to test your knowledge of incidence and screening in prostate cancer. Here’s your first question:

1.  Nearly half of U.S. prostate cancer deaths occur in men diagnosed after the age of ____.

A.74 years

B.76 years

C.78 years

D.80 years


 

 

Recent Videos
Biochemical markers and advanced imaging modalities play a critical role in monitoring patients undergoing RLT therapy for metastatic prostate cancer.
Data support the use of radioligand therapy in combination with androgen receptor pathway inhibitors to optimize prostate cancer outcomes.
Prior studies, like the phase 3 VISION trial, may support the notion of combining radiopharmaceuticals with best supportive care.
Beta emitters like 177Lu-rosopatamab may offer built-in PSMA imaging during the treatment of patients with metastatic castration-resistant prostate cancer.
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Related Content